Question 1

What is Gossamer Bio's focus?

Accepted Answer

Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Question 2

What are Gossamer Bio's key goals?

Accepted Answer

Gossamer Bio's key goals are to enhance the lives of people living with rare diseases like PAH and PH-ILD through the development and commercialization of seralutinib.

Question 3

Where can I find more information about Gossamer Bio and seralutinib?

Accepted Answer

You can find more information about Gossamer Bio, seralutinib, and the PROSERA study on the company's website at www.gossamberbio.com. The website provides details on the company's overview, team, management, board of directors, as well as information on the science, patients, and investors.

Gossamer Bio

Company Overview

Company Name

Address

Website

Approx. Annual Revenue

Employees

About Gossamer Bio

Frequently Asked Questions about Gossamer Bio

What is Gossamer Bio's focus?

What are Gossamer Bio's key goals?

Where can I find more information about Gossamer Bio and seralutinib?

Technologies Used

Social Profiles

Key Decision Makers